O'Grady Brendan P.
Insider CIK 1726533 · ASRT CEO, Director · TEVA EVP, North America Commercial
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ASRT Assertio Holdings, Inc. | M Exercise deriv | 2025-05-31 | 2025-06-03 | 166,665 | — | $0 | 333,335 | SEC↗ |
| ASRT Assertio Holdings, Inc. | M Exercise | 2025-05-31 | 2025-06-03 | 166,665 | — | $0 | 178,371 | SEC↗ |
| ASRT Assertio Holdings, Inc. | F Tax w/h | 2025-05-31 | 2025-06-03 | 49,416 | $0.66 | $32.6K | 128,955 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award deriv | 2025-02-18 | 2025-02-20 | 500,000 | — | $0 | 500,000 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award deriv | 2025-02-18 | 2025-02-20 | 755,525 | — | $0 | 755,525 | SEC↗ |
| ASRT Assertio Holdings, Inc. | P Buy | 2024-11-14 | 2024-11-15 | 11,706 | $0.85 | $10.0K | 11,706 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award deriv | 2024-05-31 | 2024-06-04 | 1,800,000 | — | $0 | 1,800,000 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award deriv | 2024-05-31 | 2024-06-04 | 500,000 | — | $0 | 500,000 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2021-03-05 | 2021-03-08 | 109,315 | — | $0 | 109,315 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-05 | 2021-03-08 | 11,436 | $10.54 | $120.5K | 14,868 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-03-04 | 2021-03-08 | 18,905 | — | $0 | 37,811 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-03-04 | 2021-03-08 | 18,905 | — | $0 | 33,773 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-04 | 2021-03-08 | 7,469 | $10.57 | $78.9K | 26,304 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-04 | 2021-03-08 | 703 | $10.80 | $7.6K | 14,868 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-03-03 | 2021-03-04 | 1,166 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-03 | 2021-03-04 | 463 | $10.86 | $5.0K | 15,571 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-03-03 | 2021-03-04 | 1,166 | — | $0 | 16,034 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-02 | 2021-03-04 | 15,085 | $10.85 | $163.7K | 14,868 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-01 | 2021-03-02 | 9,849 | $10.83 | $106.7K | 93,231 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-01 | 2021-03-02 | 63,278 | $10.93 | $691.6K | 29,953 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-02-28 | 2021-03-02 | 24,934 | — | $0 | 74,805 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-02-28 | 2021-03-02 | 24,934 | — | $0 | 103,080 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-02-09 | 2021-02-11 | 16,120 | — | $0 | 16,121 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award | 2021-02-09 | 2021-02-11 | 67,852 | — | $0 | 98,840 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-02-09 | 2021-02-11 | 16,720 | $12.69 | $212.2K | 78,146 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-02-09 | 2021-02-11 | 3,974 | $12.69 | $50.4K | 94,866 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-02-09 | 2021-02-11 | 16,120 | — | $0 | 30,988 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-03-17 | 2020-03-19 | 1,179 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-03-17 | 2020-03-19 | 1,179 | — | $0 | 15,338 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-03-17 | 2020-03-19 | 470 | $7.16 | $3.4K | 14,868 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-03-03 | 2020-03-05 | 1,166 | — | $0 | 1,166 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-03-03 | 2020-03-05 | 463 | $11.37 | $5.3K | 14,159 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-03-03 | 2020-03-05 | 1,166 | — | $0 | 14,622 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2020-02-28 | 2020-03-03 | 99,739 | — | $0 | 99,739 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-02-10 | 2020-02-11 | 4,799 | $12.27 | $58.9K | 13,456 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-02-09 | 2020-02-11 | 16,120 | — | $0 | 32,241 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-02-09 | 2020-02-11 | 16,120 | — | $0 | 18,255 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-09-18 | 2019-09-20 | 1,241 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-09-18 | 2019-09-20 | 1,241 | — | $0 | 2,629 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-09-18 | 2019-09-20 | 494 | $7.83 | $3.9K | 2,135 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-03-18 | 2019-03-19 | 1,179 | $16.63 | $19.6K | 1,388 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-03-17 | 2019-03-19 | 1,179 | — | $0 | 1,179 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-03-17 | 2019-03-19 | 1,179 | — | $0 | 2,567 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-03-12 | 2019-03-14 | 738 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-03-12 | 2019-03-14 | 738 | — | $0 | 2,126 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-03-12 | 2019-03-14 | 738 | $15.67 | $11.6K | 1,388 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2019-03-04 | 2019-03-06 | 56,716 | — | $0 | 56,716 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-03-04 | 2019-03-05 | 1,166 | $16.88 | $19.7K | 1,388 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-03-03 | 2019-03-05 | 1,166 | — | $0 | 2,332 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-03-03 | 2019-03-05 | 1,166 | — | $0 | 2,554 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-09-18 | 2018-09-20 | 1,241 | — | $0 | 1,241 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-09-18 | 2018-09-20 | 1,241 | — | $0 | 2,629 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-09-18 | 2018-09-20 | 1,241 | $23.71 | $29.4K | 1,388 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-03-19 | 2018-03-20 | 1,179 | $17.88 | $21.1K | 1,388 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-03-17 | 2018-03-20 | 1,179 | — | $0 | 2,358 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-03-17 | 2018-03-20 | 1,179 | — | $0 | 2,567 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-03-12 | 2018-03-14 | 738 | — | $0 | 738 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-03-12 | 2018-03-14 | 738 | $19.49 | $14.4K | 1,388 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-03-12 | 2018-03-14 | 738 | — | $0 | 2,126 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | F Tax w/h | 2018-03-05 | 2018-03-06 | 461 | $19.38 | $8.9K | 2,093 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-03-05 | 2018-03-06 | 705 | $19.38 | $13.7K | 1,388 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-03-03 | 2018-03-06 | 1,166 | — | $0 | 3,498 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-03-03 | 2018-03-06 | 1,166 | — | $0 | 2,554 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2018-02-09 | 2018-02-12 | 123,288 | — | $0 | 123,288 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2018-02-09 | 2018-02-12 | 48,361 | — | $0 | 48,361 | SEC↗ |